Elizabeth Snyder, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2214 Canterbury Dr Ste 202, Hays, KS 67601 Phone: 785-623-2312 |
Dr. Patrick Scott Atkinson, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2509 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5095 Fax: 785-623-5080 |
Justin Helberg, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5591 Fax: 785-623-5054 |
Kayla Gray, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2220 Canterbury Dr, Hays, KS 67601 Phone: 785-623-5591 Fax: 785-623-5045 |
News Archive
New research shows that the agents commonly mixed with cannabis oil for vaping can also produce cancer-causing compounds when heated.
Researchers at the University of Rochester believe they have just confirmed a controversial theory of evolution.
Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.
› Verified 7 days ago